医学
心房颤动
危险系数
内科学
冲程(发动机)
导管消融
心脏病学
前瞻性队列研究
倾向得分匹配
置信区间
队列
队列研究
比例危险模型
烧蚀
机械工程
工程类
作者
Xin Su,Xin Du,Shangxin Lu,Chao Jiang,Jing Du,Shijun Xia,Zhaojie Dong,Zhaoxu Jia,Deyong Long,Caihua Sang,Ribo Tang,Nian Liu,Songnan Li,Rong Bai,Jianzeng Dong,Changsheng Ma
出处
期刊:PubMed
日期:2020-12-28
卷期号:17 (12): 740-749
被引量:11
标识
DOI:10.11909/j.issn.1671-5411.2020.12.008
摘要
It is unclear whether catheter ablation (CA) for atrial fibrillation (AF) affects the long-term prognosis in the elderly. This study aims to evaluate the relationship between CA and long-term outcomes in elderly patients with AF.Patients more than 75 years old with non-valvular AF were prospectively enrolled between August 2011 and December 2017 in the Chinese Atrial Fibrillation Registry Study. Participants who underwent CA at baseline were propensity score matched (1:1) with those who did not receive CA. The outcome events included all-cause mortality, cardiovascular mortality, stroke/transient ischemic attack (TIA), and cardiovascular hospitalization.Overall, this cohort included 571 ablated patients and 571 non-ablated patients with similar characteristics on 18 dimensions. During a mean follow-up of 39.75 ± 19.98 months (minimum six months), 24 patients died in the ablation group, compared with 60 deaths in the non-ablation group [hazard ratio (HR) = 0.49, 95% confidence interval (CI): 0.30-0.79, P = 0.0024]. Besides, 6 ablated and 29 non-ablated subjects died of cardiovascular disease (HR = 0.25, 95% CI: 0.11-0.61, P = 0.0022). A total of 27 ablated and 40 non-ablated patients suffered stroke/TIA (HR = 0.79, 95% CI: 0.48-1.28, P = 0.3431). In addition, 140 ablated and 194 non-ablated participants suffered cardiovascular hospitalization (HR = 0.84, 95% CI: 0.67-1.04, P = 0.1084). Subgroup analyses according to gender, type of AF, time since onset of AF, and anticoagulants exposure in initiation did not show significant heterogeneity.In elderly patients with AF, CA may be associated with a lower incidence of all-cause and cardiovascular mortality.
科研通智能强力驱动
Strongly Powered by AbleSci AI